Top U.S. cancer centers have launched a federated AI platform, letting models learn from patient data securely to accelerate ...
Interinstitutional Approach to Advancing Geospatial Technologies for US Cancer Centers OncotypeDx offers another example of potential harm when not considering basic demographics in large-scale data ...
In an effort to foster progress in cancer research, the National Institute of Standards and Technology (NIST) is releasing detailed and comprehensive data about the entire genetic content of a ...
Combined Transcriptome and Circulating Tumor DNA Longitudinal Biomarker Analysis Associates With Clinical Outcomes in Advanced Solid Tumors Treated With Pembrolizumab The prognostic model demonstrated ...
The annual cancer statistics report from the National Cancer Institute (NCI) — which was published in the journal Cancer on Monday, April 21 — shows some signs of progress in America’s fight against ...
Poolbeg Pharma, the clinical-stage biopharmaceutical company cofounded by serial entrepreneur Cathal Friel, has said it ...
President Donald Trump signed an executive order Tuesday meant to bring AI tools to bear on the challenge of pediatric cancer ...
President Donald Trump signed an executive order aiming to use artificial intelligence to improve pediatric cancer diagnosis ...
In 2024, just over 2 million people in the United States were estimated to be diagnosed with cancer — 29,980 of them were from Louisiana, the American Cancer Society predicted. Prostate cancer and ...
The US FDA has accepted the supplemental biologics license application (sBLA) for trastuzumab deruxtecan (T-DXd; Enhertu) followed by paclitaxel (Taxol), trastuzumab (Herceptin), and pertuzumab ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback